Skip to main content

Journals in Life sciences

Elsevier's Life Science collection helps researchers get comprehensive coverage and up-to-date information on the study of living organisms, their processes, and interrelationships, spanning disciplines like biology, genetics, and biochemistry, and addressing emerging trends such as genomics, biotechnology, and sustainability, essential for advancing knowledge and driving innovation in the field.

1-10 of 432 results in All results

AACE Clinical Case Reports

  • ISSN: 2376-0605
AACE Clinical Case Reports provides clinically relevant research, including high-impact case reports, visual and video vignettes, and more, that serve as learning opportunities for practicing endocrinologists and the endocrine care community. It is the official open access journal of the American Association of Clinical Endocrinology.
AACE Clinical Case Reports

Achievements in the Life Sciences

  • ISSN: 2078-1520
Achievements in the Life Sciences publishes articles within phenomenon studying under the name "Life". Articles considering "Life" from the point of view of biology, physics, chemistry, geology, mathematics, philosophy, medicine, philology and any other scientific directions are accepted to the publication.Achievements in the Life Sciences accept original papers and reviews.The Journal published papers in the interdisciplinary fields: -biochemistry -biogeology -biogeography -biophysics -biomedicine -biomaterial, etcThe main condition for acceptance is achievement of message.
Achievements in the Life Sciences

Acta Histochemica

  • ISSN: 0065-1281
  • 5 Year impact factor: 2.5
  • Impact factor: 2.5
Research and Methods in Cell and Tissue BiologyActa Histochemica is a classic scientific journal established in 1954 currently focused on basic research and methodological innovations in cell and tissue biology. The aim of the journal is to promote the peer-reviewed publication of original articles and short communications reporting novel results and experimental approaches in the field, as well as comprehensive reviews, letters to the editor and meeting reports, serving as an open forum for the cell and histochemical research community. Manuscripts analysing the mechanisms of functional regulation of living systems at a cell/tissue level, in physiological or pathological conditions, or reporting new techniques and methodological approaches to quantify/visualize cellular activities are particularly welcomed.
Acta Histochemica

Acta Oecologica

  • ISSN: 1146-609X
  • 5 Year impact factor: 1.8
  • Impact factor: 1.8
Acta Oecologica is venue for the publication of original research articles in ecology. We encourage studies in all areas of ecology, including ecosystem ecology, community ecology, population ecology, conservation ecology and evolutionary ecology. There is no bias with respect to taxon, biome or geographic area. Both theoretical and empirical papers are welcome, but combinations are particularly sought. Priority is given to papers based on explicitly stated hypotheses. Acta Oecologica also accepts review papers.The forum section is reserved for short papers with critical discussion of current issues in ecology, as well as comments and viewpoints on previously published papers. Acta Oecologica does not publish book reviews, but comments on new books are welcome in the forum section.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Acta Oecologica

Advanced Bionics

  • ISSN: 2950-3876
Advanced Bionics (ABS) is an international peer-reviewed, open access journal that publishes original research papers, reviews, letters, editorials, highlights, perspectives, comments and news.ABS focuses on the study of novel principles and functions observed in biological systems, as well as the application of this knowledge to address real-world scientific challenges.ABS aims to lead advancements in fundamental bionic research, pushing the boundaries of novel bionic investigations and fostering disruptive technologies within the field. Submissions to the journal are expected to provide fresh insights, possess scientific impact and a high level of quality, as well as contribute to shaping the future of bionic research.As an interdisciplinary journal, ABS covers a wide array of topics, including but not limited to:(1) Bionic Robotics, Electronics, and Intelligent Devices (2) Bio-inspired Artificial Intelligence (3) Biomechanics and Bionic Healthcare Engineering (4) Bio-inspired Functional Surfaces/Interfaces (5) Bio-inspired Functional Materials and Biosensors (6) Bio-inspired Energy System (7) Bio-manufacturing and Bionic Manufacturing (8) Bio-inspired structures and design
Advanced Bionics

Advanced Drug Delivery Reviews

  • ISSN: 0169-409X
  • 5 Year impact factor: 17.7
  • Impact factor: 16.1
The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery.In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution.Theme issues are commissioned by one of the Executive Editors or the Editor-in-Chief. The Journal does not publish stand alone manuscripts. If you wish to submit a theme issue topic for consideration, please contact one of the editors.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Advanced Drug Delivery Reviews

Advances in Biological Regulation

  • ISSN: 2212-4926
Advances in Biological Regulation (formerly Advances in Enzyme Regulation) reports cutting edge scientific progress on regulation at the molecular level, covering:The molecular biology of control of gene expression by hormones, drugs and growth factors in cancer cells and in clinical situations of metabolic diseases, inborn errors of metabolism and neoplasia.Stem cell biology and regenerative medicine issuesRegulatory networks, mainly in cellular signalling, differentiation, cell cycle & growth control, structure-function relationships, cell fate and lineage commitment or assembly mechanisms in cellsViruses, or supramolecular constructs, and signaling mechanisms mediating transcriptionGenomic, proteomic, bioinformatics and systems biology approaches to identify and characterize steps of biological control in cells.Complex cellular, pathogenic, clinical, or animal model systems studied by biochemical, molecular, genetic, epigenetic or quantitative ultrastructural approaches
Advances in Biological Regulation

Advances in Biomarker Sciences and Technology

  • ISSN: 2543-1064
Advances in Biomarker Sciences and Technology (ABST) is a rigorously peer-reviewed, fully open access journal that aims to encompass all aspects of biomarker research, from biomarker development to its applications, clinical diagnosis and treatment to molecular epidemiology and toxicology; from precision medicine to drug development, and from nanotechnology to bioinformatics. ABST focuses on building upon the next generation of biomarkers to accelerate communication of the latest advances in their identification as well as applications. We strive to achieve this objective by providing a high-quality forum for the publication of biomarker-related investigations, including (but not limited to) general research articles elucidating topics in novel technologies, study designs or mathematical models, invited and selected reviews, short communications and editorials.
Advances in Biomarker Sciences and Technology

Advances in Cancer Biology - Metastasis

  • ISSN: 2667-3940
Despite the progress in cancer diagnostic and treatment, the problem of cancer metastasis is still unsolved. Approximately 90% of cancer patients die due to the metastatic disease progression. It is assumed that elucidation of the molecular mechanisms associated with cancer cell spread to the distant organs and tissues could help in the improvement of therapy results and clinical outcome in cancer patients.The journal devotes itself to the publication of basic and translational research. It accepts reviews, research articles, mini-reviews and technical (methodology) papers. More clinically-oriented papers may also be accepted if they discuss therapeutic options dependent on specific molecular features of the primary and secondary (metastatic) tumors.Manuscripts addressing the following problems are especially welcome:Molecular mechanisms underlying metastatic spread;Molecular properties of carcinoma cells associated with their metastatic capacities;Molecular mechanisms of organ-specific metastasis;Role of microenvironment (tumor stroma and immune system) in metastatic progression;Site-specific metastasis;Tumor metabolism and metastatic spread;Cancer metastasis and dormancy;Role of cancer stem cells in the metastasis development;Circulating tumor cells;Exosomes and microvesicles in disease progression;Therapy-induced metastasis;Animal models to study the mechanisms of metastatic spread;Preclinical findings that could be useful in the clinical practice to combat metastatic disease;Diagnostic tools for metastasis detection;Translational research on metastatic disease;Therapeutic approaches to combat metastatic progression.Should you have a proposal or an idea for a thematic issue, please complete the thematic issue proposal form and send it to the Editorial Office (Ms. Carly Middendorp, [email protected]).
Advances in Cancer Biology - Metastasis

Advances in Radiation Oncology

  • ISSN: 2452-1094
  • 5 Year impact factor: 2.5
  • Impact factor: 2.3
An official journal of the American Society for Radiation OncologyAdvances in Radiation Oncology is a peer reviewed, wide-ranging open access journal from the American Society for Radiation Oncology (ASTRO). Included in PubMed Central, Advances complements the research in the International Journal of Radiation Oncology • Biology • Physics and Practical Radiation Oncology. The mission of Advances in Radiation Oncology is to provide original clinical research aimed at improving the lives of people living with cancer and other diseases treated with radiation therapy. The purpose of Advances is to provide information for clinicians who use radiation therapy by publishing:Clinical trial reports and reanalyses.Basic science original reports.Manuscripts examining health services research, comparative and cost effectiveness research, and systematic reviews.Case reports documenting unusual problems and solutions.High quality multi and single institutional series, as well as other novel retrospective hypothesis generating series.Timely critical reviews on important topics in radiation oncology, such as side effects.Articles reporting the natural history of disease and patterns of failure, particularly as they relate to treatment volume delineation.Articles on safety and quality in radiation therapy.Essays on clinical experience.Articles on practice transformation in radiation oncology, in particular:Aspects of health policy that may impact the future practice of radiation oncology.How information technology, such as data analytics and systems innovations, will change radiation oncology practice.Articles on imaging as they relate to radiation therapy treatment.Advances is a gold open access journal, so authors, readers and patients have free access to all articles. All work published by this journal is thoroughly peer reviewed by the editorial board and expert reviewers in radiation oncology. Authors retain copyright of their articles and reuse is governed under a Creative Commons license so that readers can freely and easily share information. Learn more about the types of articles sought by the editorial team.Disclaimer The views expressed in Advances in Radiation Oncology (the "Journal") are those of the individual authors and are not necessarily those of the American Society for Radiation Oncology (ASTRO) or the Publisher. The information contained in the Journal is not medical advice and is not intended to replace the judgment of a practitioner with respect to particular patients, procedures, or practice. No responsibility is assumed by the Publisher nor by the Society for any injury and/or damage to persons or property as a result of (i) any actual or alleged libellous statements or infringement of intellectual property or privacy rights, (ii) product liability or negligence; (iii) an author's statements or other materials; or (iv) the use or operation of any ideas, instructions, procedures, products, or methods contained in the Journal. Due to rapid advances in the medical sciences, independent verification of diagnoses and drug dosages should always be made. In any jurisdiction that does not permit such a disclaimer of liability, the liability of ASTRO and the Publisher shall be limited to the greatest extent allowed by applicable law.Publication of an advertisement in the Journal does not constitute on the part of the Publisher or the Society a guarantee or endorsement of the quality or value of the advertised products or services described therein or of any of the representations or the claims made by the advertisers with respect to such products or services.
Advances in Radiation Oncology